Crossmark

The potential effects of the synergistic interaction between ferulic acid and new generation CDK inhibitor anti-neoplastic drugs on breast cancer anti-tumour activity

Crossref DOI link: https://doi.org/10.1007/s12032-025-03181-7

Published Online: 2025-12-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bayav, Ibrahim

Ergezgin, Huriye

Tokgun, Pervin Elvan

Tomatir, Ayse Gaye
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (124S380)
License Information

Text and Data Mining valid from 2025-12-11

Version of Record valid from 2025-12-11
More Information

Article History

Received: 12 August 2025

Accepted: 3 December 2025

First Online: 11 December 2025

Declarations

:

: The authors declare no competing interests.

: No ethical approval is required for this study.

Document is current

Any future updates will be listed below